Skip to main content
EDSA
NASDAQ Life Sciences

Edesa Biotech's Paridiprubart Shows 32% Mortality Reduction in Exploratory AKI Data

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$7.62
Mkt Cap
$63.044M
52W Low
$0.72
52W High
$20.32
52W Position info
958% above low
Off High info
63% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

EDSA has more than doubled off its 52-week low of $0.72 on light trading volume (0.1× avg).

Summary

Edesa Biotech announced positive exploratory clinical data for its drug paridiprubart in patients with acute kidney injury (AKI). The data showed a 32% relative reduction in 28-day mortality and a 23% relative reduction in major adverse kidney events (MAKE30) in a combined cohort of 101 patients. This news, also disclosed in an 8-K today, provides a significant positive development for the clinical-stage biotech, which recently reported a wider net loss and a going concern warning. While the findings are exploratory and require confirmatory studies, the magnitude of the observed benefit in a high-mortality condition is highly material.

At the time of this announcement, EDSA was trading at $7.62 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $63M. The 52-week trading range was $0.72 to $20.32. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

EDSA - Latest Insights

EDSA
Nov 17, 2026, 9:25 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.94
Real-time Price: $2.07 info
Change: +$0.130 (+7%) info
Market Cap: $27.969M info
EDSA
Nov 09, 2026, 6:05 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $2.35
Real-time Price: $2.07 info
Change: -$0.280 (-12%) info
Market Cap: $27.969M info
EDSA
Nov 09, 2026, 6:00 AM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $2.53
Real-time Price: $2.07 info
Change: -$0.4582 (-18%) info
Market Cap: $27.969M info
EDSA
Oct 23, 2026, 5:24 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.77
Real-time Price: $2.07 info
Change: -$0.700 (-25%) info
Market Cap: $27.969M info
EDSA
Oct 15, 2026, 9:15 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.62
Real-time Price: $2.07 info
Change: -$0.550 (-21%) info
Market Cap: $27.969M info